Cargando…
Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition
Oestrogen receptor (ER)-positive breast cancer is responsive to a number of targeted therapies used clinically. Unfortunately, the continuous application of any targeted therapy often results in resistance to the therapy. Our ultimate goal is to use mathematical modelling to optimize alternating the...
Autores principales: | He, Wei, Demas, Diane M., Conde, Isabel P., Shajahan-Haq, Ayesha N., Baumann, William T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482571/ https://www.ncbi.nlm.nih.gov/pubmed/32842890 http://dx.doi.org/10.1098/rsif.2020.0339 |
Ejemplares similares
-
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
por: Fallah, Yassi, et al.
Publicado: (2021) -
Modeling breast cancer proliferation, drug synergies, and alternating therapies
por: He, Wei, et al.
Publicado: (2023) -
Mathematical modelling with Bayesian inference to quantitatively characterize therapeutic cell behaviour in nerve tissue engineering
por: Berg, Maxime, et al.
Publicado: (2023) -
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
por: Scheidemann, Erin R., et al.
Publicado: (2021) -
Using collision cones to assess biological deconfliction methods
por: Brace, Natalie L., et al.
Publicado: (2016)